-
Je něco špatně v tomto záznamu ?
Angiogenic activity in patients with psoriasis is significantly decreased by Goeckerman's therapy
C Andrys, L Borska, D Pohl, Z Fiala, K Hamakova, J Krejsek
Jazyk angličtina Země Německo
Grantová podpora
NR8154
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Část
Zdroj
NLK
SpringerLink Journals
od 1997-01-01 do 2009-03-31
ProQuest Central
od 2001-02-01 do 2018-12-31
Medline Complete (EBSCOhost)
od 2000-01-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 2001-02-01 do 2018-12-31
- MeSH
- dehet uhelný terapeutické užití MeSH
- dospělí MeSH
- fibroblastový růstový faktor 2 krev MeSH
- financování organizované MeSH
- kombinovaná terapie MeSH
- kůže krevní zásobení MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- patologická angiogeneze patofyziologie terapie MeSH
- psoriáza patofyziologie terapie MeSH
- senioři MeSH
- stupeň závažnosti nemoci MeSH
- terapie ultrafialovými paprsky MeSH
- ultrafialové záření MeSH
- vaskulární endoteliální růstový faktor A krev MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
Goeckerman's therapy (GT) of psoriasis is based on daily application of pharmacy grade coal tar on affected skin with subsequent exposure to UV light. Goeckerman's therapy is still the first line therapy of psoriasis in the Czech Republic because of its low cost and long-term efficacy. Disturbances in angiogenic activity are characteristic for the immunopathogenesis of psoriasis. An abnormal spectrum of cytokines, growth factors and proangiogenic mediators is produced by keratinocytes and inflammatory cells in patients suffering from the disease. The aim of this study was to evaluate the influence of GT of psoriasis on angiogenic activities by comparing serum levels of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in 44 patients with psoriasis in peripheral blood samples collected before and after therapy. Forty otherwise healthy blood donors serve as a control group. The efficacy of GT was delineated by psoriasis area and severity index (PASI). The disease activity was significantly diminished by GT (P < 0.001). The serum levels of both VEGF and bFGF were statistically significantly correlated to PASI value in patients before the treatment by GT. The serum levels of VEGF (329.4 +/- 125.5 microg/ml) and bFGF (10.2 +/- 5.04 pg/ml) in patients before GT were significantly higher than those measured in healthy blood donors (VEGF 236.4 +/- 55.9 pg/ml, bFGF 7.3 +/- 3.7 pg/ ml). The serum levels of both VEGF and bFGF were significantly diminished by GT. The level of VEGF dropped from 329.4 +/- 125.5 pg/ml before GT to 278.5 +/- 109.9 pg/ml after GT (P = 0.0042) and the level of bFGF fell from 10.2 +/- 5.04 to 7.78 +/- 4.5 pg/ml (P = 0.019). Comparing to healthy controls, the serum level of bFGF in psoriasis patients was normalised (P = 0.5723) after GT. In contrast, the serum level of VEGF remained significantly increased in psoriasis patients after GT in comparison with healthy blood donors (P = 0.0319). In conclusion, we found that the angiogenic potential which is abnormally increased in patients with psoriasis is significantly alleviated by GT.
- 000
- 03971naa 2200493 a 4500
- 001
- bmc10010204
- 003
- CZ-PrNML
- 005
- 20130815101828.0
- 008
- 100429s2007 gw e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Andrýs, Ctirad, $d 1962- $7 mzk2008430528
- 245 10
- $a Angiogenic activity in patients with psoriasis is significantly decreased by Goeckerman's therapy / $c C Andrys, L Borska, D Pohl, Z Fiala, K Hamakova, J Krejsek
- 314 __
- $a Department of Clinical Immunology and Allergy, School of Medicine, Charles University in Prague, Hradec Kralove, Czech Republic. andrys@lfhk.cuni.cz
- 520 9_
- $a Goeckerman's therapy (GT) of psoriasis is based on daily application of pharmacy grade coal tar on affected skin with subsequent exposure to UV light. Goeckerman's therapy is still the first line therapy of psoriasis in the Czech Republic because of its low cost and long-term efficacy. Disturbances in angiogenic activity are characteristic for the immunopathogenesis of psoriasis. An abnormal spectrum of cytokines, growth factors and proangiogenic mediators is produced by keratinocytes and inflammatory cells in patients suffering from the disease. The aim of this study was to evaluate the influence of GT of psoriasis on angiogenic activities by comparing serum levels of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in 44 patients with psoriasis in peripheral blood samples collected before and after therapy. Forty otherwise healthy blood donors serve as a control group. The efficacy of GT was delineated by psoriasis area and severity index (PASI). The disease activity was significantly diminished by GT (P < 0.001). The serum levels of both VEGF and bFGF were statistically significantly correlated to PASI value in patients before the treatment by GT. The serum levels of VEGF (329.4 +/- 125.5 microg/ml) and bFGF (10.2 +/- 5.04 pg/ml) in patients before GT were significantly higher than those measured in healthy blood donors (VEGF 236.4 +/- 55.9 pg/ml, bFGF 7.3 +/- 3.7 pg/ ml). The serum levels of both VEGF and bFGF were significantly diminished by GT. The level of VEGF dropped from 329.4 +/- 125.5 pg/ml before GT to 278.5 +/- 109.9 pg/ml after GT (P = 0.0042) and the level of bFGF fell from 10.2 +/- 5.04 to 7.78 +/- 4.5 pg/ml (P = 0.019). Comparing to healthy controls, the serum level of bFGF in psoriasis patients was normalised (P = 0.5723) after GT. In contrast, the serum level of VEGF remained significantly increased in psoriasis patients after GT in comparison with healthy blood donors (P = 0.0319). In conclusion, we found that the angiogenic potential which is abnormally increased in patients with psoriasis is significantly alleviated by GT.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a dehet uhelný $x terapeutické užití $7 D003033
- 650 _2
- $a kombinovaná terapie $7 D003131
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a fibroblastový růstový faktor 2 $x krev $7 D016222
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a patologická angiogeneze $x patofyziologie $x terapie $7 D009389
- 650 _2
- $a psoriáza $x patofyziologie $x terapie $7 D011565
- 650 _2
- $a stupeň závažnosti nemoci $7 D012720
- 650 _2
- $a kůže $x krevní zásobení $7 D012867
- 650 _2
- $a ultrafialové záření $7 D014466
- 650 _2
- $a terapie ultrafialovými paprsky $7 D014467
- 650 _2
- $a vaskulární endoteliální růstový faktor A $x krev $7 D042461
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Borská, Lenka $7 nlk20060173900
- 700 1_
- $a Pohl, David $7 xx0104099
- 700 1_
- $a Fiala, Zdeněk, $d 1955- $7 nlk19990073147
- 700 1_
- $a Hamáková, Květoslava $7 xx0064204
- 700 1_
- $a Krejsek, Jan, $d 1958- $7 nlk19990073429
- 773 0_
- $t Archives of Dermatological Research $w MED00009242 $g Roč. 298, č. 10 (2007), s. 479-483 $x 0340-3696
- 910 __
- $a ABA008 $b x $y 8
- 990 __
- $a 20100519111533 $b ABA008
- 991 __
- $a 20130815102338 $b ABA008
- 999 __
- $a ok $b bmc $g 724065 $s 587198
- BAS __
- $a 3
- BMC __
- $a 2007 $b 298 $c 10 $d 479-483 $i 0340-3696 $m Archives of dermatological research $n Arch Dermatol Res $x MED00009242
- GRA __
- $a NR8154 $p MZ0
- LZP __
- $a 2010-B2/dkme